These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23474223)

  • 1. Whole transcriptome analysis of the ERα synthetic fragment P295-T311 (ERα17p) identifies specific ERα-isoform (ERα, ERα36)-dependent and -independent actions in breast cancer cells.
    Notas G; Kampa M; Pelekanou V; Troullinaki M; Jacquot Y; Leclercq G; Castanas E
    Mol Oncol; 2013 Jun; 7(3):595-610. PubMed ID: 23474223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERα17p, an ERα P295 -T311 fragment, modifies the migration of breast cancer cells, through actin cytoskeleton rearrangements.
    Kampa M; Pelekanou V; Gallo D; Notas G; Troullinaki M; Pediaditakis I; Charalampopoulos I; Jacquot Y; Leclercq G; Castanas E
    J Cell Biochem; 2011 Dec; 112(12):3786-96. PubMed ID: 21826705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The estrogen receptor alpha-derived peptide ERα17p (P(295)-T(311)) exerts pro-apoptotic actions in breast cancer cells in vitro and in vivo, independently from their ERα status.
    Pelekanou V; Kampa M; Gallo D; Notas G; Troullinaki M; Duvillier H; Jacquot Y; Stathopoulos EN; Castanas E; Leclercq G
    Mol Oncol; 2011 Feb; 5(1):36-47. PubMed ID: 21163714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trophic effect in MCF-7 cells of ERalpha17p, a peptide corresponding to a platform regulatory motif of the estrogen receptor alpha--underlying mechanisms.
    Gallo D; Haddad I; Duvillier H; Jacquemotte F; Laïos I; Laurent G; Jacquot Y; Vinh J; Leclercq G
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):138-49. PubMed ID: 18262408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory function of the P295-T311 motif of the estrogen receptor alpha - does proteasomal degradation of the receptor induce emergence of peptides implicated in estrogenic responses?
    Gallo D; Haddad I; Laurent G; Vinh J; Jacquemotte F; Jacquot Y; Leclercq G
    Nucl Recept Signal; 2008 Apr; 6():e007. PubMed ID: 18432312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-α36 (ERα36).
    Chaudhri RA; Olivares-Navarrete R; Cuenca N; Hadadi A; Boyan BD; Schwartz Z
    J Biol Chem; 2012 Mar; 287(10):7169-81. PubMed ID: 22247547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERα36, a new variant of the ERα is expressed in triple negative breast carcinomas and has a specific transcriptomic signature in breast cancer cell lines.
    Pelekanou V; Notas G; Kampa M; Tsentelierou E; Radojicic J; Leclercq G; Castanas E; Stathopoulos EN
    Steroids; 2012 Aug; 77(10):928-34. PubMed ID: 22198466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay of estrogen receptors and GPR30 for the regulation of early membrane initiated transcriptional effects: A pharmacological approach.
    Notas G; Kampa M; Pelekanou V; Castanas E
    Steroids; 2012 Aug; 77(10):943-50. PubMed ID: 22138208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic responses from the estrogen-responsive element-dependent signaling pathway mediated by estrogen receptor alpha are required to elicit cellular alterations.
    Nott SL; Huang Y; Li X; Fluharty BR; Qiu X; Welshons WV; Yeh S; Muyan M
    J Biol Chem; 2009 May; 284(22):15277-88. PubMed ID: 19321454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calmodulin, a regulatory partner of the estrogen receptor alpha in breast cancer cells.
    Gallo D; Jacquot Y; Laurent G; Leclercq G
    Mol Cell Endocrinol; 2008 Sep; 291(1-2):20-6. PubMed ID: 18524472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of the anti-proliferative activity of the peptide ERα17p in MCF-7 breast cancer cells using nanodiamonds.
    Yip F; Nemati F; El Botty R; Belnou M; Decaudin D; Mansuy C; Jacquot Y
    Ann Pharm Fr; 2019 Nov; 77(6):488-495. PubMed ID: 31563266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transcriptional repressive role for epithelial-specific ETS factor ELF3 on oestrogen receptor alpha in breast cancer cells.
    Gajulapalli VN; Samanthapudi VS; Pulaganti M; Khumukcham SS; Malisetty VL; Guruprasad L; Chitta SK; Manavathi B
    Biochem J; 2016 Apr; 473(8):1047-61. PubMed ID: 26920025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor-alpha isoforms are the main estrogen receptors expressed in non-small cell lung carcinoma.
    Pelekanou V; Anastasiou E; Bakogeorgou E; Notas G; Kampa M; Garcia-Milian R; Lavredaki K; Moustou E; Chinari G; Arapantoni P; O'Grady A; Georgoulias V; Tsapis A; Stathopoulos EN; Castanas E
    Steroids; 2019 Feb; 142():65-76. PubMed ID: 29454903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sequence Pro295-Thr311 of the hinge region of oestrogen receptor α is involved in ERK1/2 activation via GPR30 in leiomyoma cells.
    Leiber D; Burlina F; Byrne C; Robin P; Piesse C; Gonzalez L; Leclercq G; Tanfin Z; Jacquot Y
    Biochem J; 2015 Nov; 472(1):97-109. PubMed ID: 26371374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estradiol-activated estrogen receptor α does not regulate mature microRNAs in T47D breast cancer cells.
    Katchy A; Edvardsson K; Aydogdu E; Williams C
    J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):145-53. PubMed ID: 22079223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells.
    Secreto FJ; Monroe DG; Dutta S; Ingle JN; Spelsberg TC
    J Cell Biochem; 2007 Aug; 101(5):1125-47. PubMed ID: 17520659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GREB1 isoforms regulate proliferation independent of ERα co-regulator activities in breast cancer.
    Haines CN; Braunreiter KM; Mo XM; Burd CJ
    Endocr Relat Cancer; 2018 Jul; 25(7):735-746. PubMed ID: 29695586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast cancer.
    Perez White B; Molloy ME; Zhao H; Zhang Y; Tonetti DA
    Mol Cancer; 2013 May; 12():34. PubMed ID: 23634843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anacardic acid inhibits estrogen receptor alpha-DNA binding and reduces target gene transcription and breast cancer cell proliferation.
    Schultz DJ; Wickramasinghe NS; Ivanova MM; Isaacs SM; Dougherty SM; Imbert-Fernandez Y; Cunningham AR; Chen C; Klinge CM
    Mol Cancer Ther; 2010 Mar; 9(3):594-605. PubMed ID: 20197399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.